AAM
CERE

Alpine Associates Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Alpine Associates Management’s Portfolio CERE Stock Details CERE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,353,694
Closed -$96.2M – 57
2024
Q2 		$96.2M Buy
2,353,694
+12,300
+0.5% +$503K 4.6% 8
2024
Q1 		$99M Buy
2,341,394
+697,294
+42% +$29.5M 3.86% 10
2023
Q4 		$69.7M Buy
+1,644,100
New +$69.7M 3.57% 11